Ligusticum chuanxiong prevents rat pheochromocytoma cells from serum deprivation-induced apoptosis through a protein kinase A-dependent pathway

Yun Lian Lin, Yi Chao Lee, Chuen Lin Huang, Wen Lin Lai, Yen Ru Lin, Nai Kuei Huang

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Ligusticum chuanxiong (LC) is a traditional Chinese herbal medicine used to treat various cardiovascular diseases. In this study, the butanol extract of LC was found to protect neuronal-like pheochromocytoma cells from serum deprivation-induced apoptosis. Both a serine/threonine kinase inhibitor and a specific protein kinase A (PKA) inhibitor blocked the protective effect of LC. A transcription inhibitor (actinomycin D) and a protein synthesis inhibitor (cyclohexamide) also attenuated the protective effect of LC, suggesting the requirement of gene expression for the protection of LC. On the other hand, LC increased both the formation of cyclic-AMP and the phosphorylation of the cyclic-AMP response element-binding protein (CREB), a downstream target of PKA and a nuclear transcription factor known for neuroprotective mechanism. Furthermore, LC-induced CREB phosphorylation and protective effect could be blocked by a PKA inhibitor and overexpression of the dominant negative CREB, respectively. Taken together, the protective mechanism of LC in antagonizing serum deprivation-induced PC12 cell apoptosis might be mediated through a PKA/CREB-dependent pathway.

Original languageEnglish
Pages (from-to)428-434
Number of pages7
JournalJournal of Ethnopharmacology
Volume109
Issue number3
DOIs
Publication statusPublished - Feb 12 2007
Externally publishedYes

Fingerprint

Ligusticum
Pheochromocytoma
Cyclic AMP-Dependent Protein Kinases
Apoptosis
Cyclic AMP Response Element-Binding Protein
Serum
Protein Kinase Inhibitors
Phosphorylation
Butanols
Protein Synthesis Inhibitors
Herbal Medicine
Protein-Serine-Threonine Kinases
PC12 Cells
Dactinomycin
Cyclic AMP
Transcription Factors
Cardiovascular Diseases
Gene Expression

Keywords

  • Apoptosis
  • Ligusticum chuanxiong
  • Pheochromocytoma cells
  • Serum deprivation

ASJC Scopus subject areas

  • Pharmacology

Cite this

Ligusticum chuanxiong prevents rat pheochromocytoma cells from serum deprivation-induced apoptosis through a protein kinase A-dependent pathway. / Lin, Yun Lian; Lee, Yi Chao; Huang, Chuen Lin; Lai, Wen Lin; Lin, Yen Ru; Huang, Nai Kuei.

In: Journal of Ethnopharmacology, Vol. 109, No. 3, 12.02.2007, p. 428-434.

Research output: Contribution to journalArticle

Lin, Yun Lian ; Lee, Yi Chao ; Huang, Chuen Lin ; Lai, Wen Lin ; Lin, Yen Ru ; Huang, Nai Kuei. / Ligusticum chuanxiong prevents rat pheochromocytoma cells from serum deprivation-induced apoptosis through a protein kinase A-dependent pathway. In: Journal of Ethnopharmacology. 2007 ; Vol. 109, No. 3. pp. 428-434.
@article{45c12875f7f045d6b85aacf48eca0b79,
title = "Ligusticum chuanxiong prevents rat pheochromocytoma cells from serum deprivation-induced apoptosis through a protein kinase A-dependent pathway",
abstract = "Ligusticum chuanxiong (LC) is a traditional Chinese herbal medicine used to treat various cardiovascular diseases. In this study, the butanol extract of LC was found to protect neuronal-like pheochromocytoma cells from serum deprivation-induced apoptosis. Both a serine/threonine kinase inhibitor and a specific protein kinase A (PKA) inhibitor blocked the protective effect of LC. A transcription inhibitor (actinomycin D) and a protein synthesis inhibitor (cyclohexamide) also attenuated the protective effect of LC, suggesting the requirement of gene expression for the protection of LC. On the other hand, LC increased both the formation of cyclic-AMP and the phosphorylation of the cyclic-AMP response element-binding protein (CREB), a downstream target of PKA and a nuclear transcription factor known for neuroprotective mechanism. Furthermore, LC-induced CREB phosphorylation and protective effect could be blocked by a PKA inhibitor and overexpression of the dominant negative CREB, respectively. Taken together, the protective mechanism of LC in antagonizing serum deprivation-induced PC12 cell apoptosis might be mediated through a PKA/CREB-dependent pathway.",
keywords = "Apoptosis, Ligusticum chuanxiong, Pheochromocytoma cells, Serum deprivation",
author = "Lin, {Yun Lian} and Lee, {Yi Chao} and Huang, {Chuen Lin} and Lai, {Wen Lin} and Lin, {Yen Ru} and Huang, {Nai Kuei}",
year = "2007",
month = "2",
day = "12",
doi = "10.1016/j.jep.2006.08.012",
language = "English",
volume = "109",
pages = "428--434",
journal = "Journal of Ethnopharmacology",
issn = "0378-8741",
publisher = "Elsevier Ireland Ltd",
number = "3",

}

TY - JOUR

T1 - Ligusticum chuanxiong prevents rat pheochromocytoma cells from serum deprivation-induced apoptosis through a protein kinase A-dependent pathway

AU - Lin, Yun Lian

AU - Lee, Yi Chao

AU - Huang, Chuen Lin

AU - Lai, Wen Lin

AU - Lin, Yen Ru

AU - Huang, Nai Kuei

PY - 2007/2/12

Y1 - 2007/2/12

N2 - Ligusticum chuanxiong (LC) is a traditional Chinese herbal medicine used to treat various cardiovascular diseases. In this study, the butanol extract of LC was found to protect neuronal-like pheochromocytoma cells from serum deprivation-induced apoptosis. Both a serine/threonine kinase inhibitor and a specific protein kinase A (PKA) inhibitor blocked the protective effect of LC. A transcription inhibitor (actinomycin D) and a protein synthesis inhibitor (cyclohexamide) also attenuated the protective effect of LC, suggesting the requirement of gene expression for the protection of LC. On the other hand, LC increased both the formation of cyclic-AMP and the phosphorylation of the cyclic-AMP response element-binding protein (CREB), a downstream target of PKA and a nuclear transcription factor known for neuroprotective mechanism. Furthermore, LC-induced CREB phosphorylation and protective effect could be blocked by a PKA inhibitor and overexpression of the dominant negative CREB, respectively. Taken together, the protective mechanism of LC in antagonizing serum deprivation-induced PC12 cell apoptosis might be mediated through a PKA/CREB-dependent pathway.

AB - Ligusticum chuanxiong (LC) is a traditional Chinese herbal medicine used to treat various cardiovascular diseases. In this study, the butanol extract of LC was found to protect neuronal-like pheochromocytoma cells from serum deprivation-induced apoptosis. Both a serine/threonine kinase inhibitor and a specific protein kinase A (PKA) inhibitor blocked the protective effect of LC. A transcription inhibitor (actinomycin D) and a protein synthesis inhibitor (cyclohexamide) also attenuated the protective effect of LC, suggesting the requirement of gene expression for the protection of LC. On the other hand, LC increased both the formation of cyclic-AMP and the phosphorylation of the cyclic-AMP response element-binding protein (CREB), a downstream target of PKA and a nuclear transcription factor known for neuroprotective mechanism. Furthermore, LC-induced CREB phosphorylation and protective effect could be blocked by a PKA inhibitor and overexpression of the dominant negative CREB, respectively. Taken together, the protective mechanism of LC in antagonizing serum deprivation-induced PC12 cell apoptosis might be mediated through a PKA/CREB-dependent pathway.

KW - Apoptosis

KW - Ligusticum chuanxiong

KW - Pheochromocytoma cells

KW - Serum deprivation

UR - http://www.scopus.com/inward/record.url?scp=33846142864&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846142864&partnerID=8YFLogxK

U2 - 10.1016/j.jep.2006.08.012

DO - 10.1016/j.jep.2006.08.012

M3 - Article

VL - 109

SP - 428

EP - 434

JO - Journal of Ethnopharmacology

JF - Journal of Ethnopharmacology

SN - 0378-8741

IS - 3

ER -